Skip to main content
BIR Issuancesby BetterGov.phBeta
Official source
Browse issuances
Revenue Memorandum Circular · RMC

RMC No. 57-2022

To publish the February 2, 2022 letter of the FDA OIC-Director General endorsing updates to the List of VAT-Exempt Medicines under Republic Act No. 11534 (CREATE Act).

Bureau of Internal RevenueIndependent research copy
Document type
RMC
Number
57
Year
2022
Text quality
Not specified

Document text

Reference copy · verify against the official source
RMC No. 57-2022 (issued April 27, 2022) publishes a February 2, 2022 letter from FDA OIC-Director General Dr. Oscar G. Gutierrez Jr. endorsing updates to the List of VAT-Exempt Medicines under Republic Act No. 11534 (CREATE Act). The updated list now includes certain medicines for hypertension, diabetes and COVID-19. The provided text is a short digest and does not contain the actual list of medicines.